Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 03, 2025 08:00 ET | Source: Arrakis Therapeutics

Arrakis Therapeutics Presents Data Highlighting Progress of Oral RNA-targeted Small Molecule to Treat Myotonic Dystrophy Type 1 (DM1)

Preclinical in vivo data demonstrate hyper-precise mechanism directly targets the disease-causing mRNA repeats leading to correction of splicing defects and reversal of myotonia Oral administration...
November 24, 2025 22:21 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Calls FDA Approval of Novartis’ Itvisma (onasemnogene abeparvovec-brve) a Major Step Forward for the Spinal Muscular Atrophy Community

New York, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today called the U.S. Food and Drug Administration’s approval of Itvisma (onasemnogene abeparvovec-brve),...
November 20, 2025 09:00 ET | Source: Muscular Dystrophy Association

NFL Players Lace Up for Muscular Dystrophy Association’s Mission in 2025 ‘My Cause My Cleats’ Campaign for Giving Tuesday

New York, Nov. 20, 2025 (GLOBE NEWSWIRE) -- This NFL season, during games in Weeks 12 and 13, hundreds of NFL players will step onto the field in custom-designed cleats as part of the 10th annual My...
November 12, 2025 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Names Sharon Hesterlee, PhD, as President and Chief Executive Officer

New York, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the appointment of Sharon Hesterlee, PhD as President and Chief Executive Officer. Dr. Hesterlee...
November 03, 2025 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Honors National Family Caregivers Month with Advocacy and Awareness Nationwide

New York, Nov. 03, 2025 (GLOBE NEWSWIRE) -- This November, the Muscular Dystrophy Association (MDA) is honoring family caregivers who provide essential support for people living with muscular...
October 21, 2025 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Advocates to Congress on November 4: Every Moment Matters in the Fight Against Muscle Loss

Washington, D.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) will bring nearly 100 advocates, scientists, and families living with neuromuscular diseases to Capitol...
October 20, 2025 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Launches Holiday Retail Campaign in Thousands of Retail Locations Nationwide

New York, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today kicked off its largest annual MDA Holiday Retail Campaign, spanning thousands of retail locations...
October 15, 2025 09:00 ET | Source: Muscular Dystrophy Association

Agenda Announced for 2026 MDA Clinical & Scientific Conference Featuring Leading Speakers Dedicated to Groundbreaking Research and Clinical Achievements in Neuromuscular Disease

New York, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the agenda including tracks and chairs for the 2026 MDA Clinical & Scientific Conference...
August 25, 2025 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Launches #MDAstrong Campaign in September During Historic 75th Anniversary, Kicking Off on Labor Day Weekend

New York, Aug. 25, 2025 (GLOBE NEWSWIRE) -- This September, the Muscular Dystrophy Association (MDA) is launching its milestone #MDAstrong campaign during a historic moment for the organization: its...
August 23, 2025 16:42 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association and Parent Project Muscular Dystrophy Announce Joint Consensus Guidelines for Safe and Equitable Delivery of Gene Therapy in Duchenne Muscular Dystrophy

New York, Aug. 23, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and Parent Project Muscular Dystrophy (PPMD) today announced the publication of jointly developed consensus...